Honored to present my recently-published research with my amazing colleagues!

Sağlıklı bir yaşam için bilimsel ve kanıtlanmış yöntemler 🎯

İşte yaşlanma sürecinde ❤️ ve metabolik sağlığınızı korumak için başvurabileceğiniz kanıta dayalı:
🔟 strateji!
EHJ Editor-in-Chief Melike Şahin European Society of Cardiology Journals #MedTwitter T.C. Sağlık Bakanlığı Ankara Üniversitesi Ankara Büyükşehir

Healthy longevity heart code!
1⃣Reduce Waist Circumference and Increase Muscle Mass
2⃣Adhere to a Minimally Processed Mediterranean-like diet
3⃣Intermittent Fasting and Time-Restricted Feeding
4⃣Be Physically Active Every Day
5⃣Avoid or Limit Alcohol Consumption
6⃣Do Not Smoke…

🚀 Attention #IMG Community! 🚀

As ASCO-IMG Research & Publication, we want to spotlight your research at the #ASCO24 ! 🌟 Let’s share your oral or poster presentation during ASCO!

👇 Fill out here: docs.google.com/spreadsheets/d…

Or contact Adeleke📧: [email protected]

12th Annual Symposium on Global Cancer Research

Great to chair this session:

🇨🇴 🇧🇼Colombia & Botswana: Transcriptomics/pharmscogenetics breast Ca
🇦🇷Argentina: Prostate Ca transcriptional reprogramming
🇪🇹Ethiopia: Conjuctival squamous cell ca ICI tx
🇺🇦Ukraine: Cancer in war

⭐️CheckMate 901 update by Dr. Guru Sonpavde Guru P. Sonpavde, MD #AUA24 Cis/Gem/Nivo vs Cis/Gem 1st line mUC cisplatin elig ✅OS👉HR 0.78
👇Cis/Gem/Nivo superior👇
✅ORR 57.6% vs 43.1%
✅CR 21.7% vs, 11.8%
✅Median CR duration 37.1 vs 13.2 mths
👇NEJM👇𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏
nejm.org/doi/pdf/10.105…

Serviks (rahim ağzı) kanseri önleminde umut verici gelişmeler var! 🇸🇪İsveç'teki bir çalışma:
💉HPV aşılama ve 🔎 taramanın bir arada uygulanmasının enfeksiyonları önemli ölçüde azaltabileceğini gösteriyor.
🔎26.000'den fazla kadının yer aldığı bu çalışma, serviks kanserinin…

🔘Promising news in cervical cancer prevention!
💉A Swedish 🇸🇪 study suggests that combining HPV vaccination and screening could lead to significant reductions in infections.
🔘With over 26,000 participants enrolled, this approach shows great potential for faster elimination…

🧬🧬🧬New research suggests that there are different rates of cancer around the world due to unknown factors in the environment.
🧬 A study on a type of kidney cancer found that the gene changes varied in different countries, indicating different causes.
🔴This shows the need…

Conventional or modern imaging modalities for #prostatecancer in 2024?

Join us & discuss with Akash Maniam, MD 🇺🇦 from Portsmouth Hospitals University NHST in presence or virtually!

Register for free 👉ow.ly/yLoL50RyqgH

#IUCS24 #urology #oncology Giuseppe Banna Ravindran Kanesvaran

🦠Yüksek yağ içeren diyetin bağırsak mikrobiyotasının (Bağırsak içinde yaşayan bakterilerden oluşan bir topluluk) bozulması yoluyla kanserlerin kötüleşme riskini arttırdığı bilinmektedir.
🧐Ancak bunu nasıl yaptığı tam olarak açık değildir.
🚨Önde gelen bilim dergisi PNASNews da…

So proud of this project on 2 levels:
(1) It showcases the hard work of our superstar City of Hope fellow Hedyeh Ebrahimi
(2) It showcases OUTSTANDING mentorship from our junior faculty member Alex Chehrazi-Raffle, MD

In this piece (reflecting a collaboration w ACCC & Genentech), they…

How Does Your Diet Impact Cancer Growth?
Exploring the Gut Connection 🚨
⭕️High-fat diets might make cancer worse by altering gut bacteria, which can help tumors grow. This shows how important diet is for cancer and suggests new ways to treat it by focusing on gut microbes!…

Guru P. Sonpavde, MD presented exploratory analyses from the Checkmate 901 study at #AUA24 . Higher quantity and quality of complete responses with gem/cis/nivo versus gem/cis in patients with metastatic bladder cancer. #BladderCancerAwarenessMonth #bladdercancer #blcsm

Our efforts to find optimal combinations with fewer adverse events while maintaining effectiveness for our patients continue.
We are extremely pleased to be involved in this study as Ankara Üniversitesi
Thank you dear Neeraj Agarwal, MD, FASCO for presenting at #AUA24
OncoAlert Arun Azad…

#AUA24 Amer. Urol. Assn. 👉Dr. Neeraj Agarwal Neeraj Agarwal, MD, FASCO presents the EvoPAR-Prostate01 phase 3 trial (trial in progress) in mHSPC #ProstateCancer with ADT+ARPI plus/minus SARUPARIB, a novel PARP1 selective inhibitor. Trial design👇 OncoAlert UroToday.com PCF Science GU Cancer Research Program @HuntsmanCancer

Our recent study has been published in #clinicalgenitourinarycancer 🤓

🧠Exciting breakthrough in brain cancer treatment!
🧠Glioblastoma (GBM) is the most aggressive primary brain cancer in adults.
🧠A new therapy with 'onion-like' structures called RNA-LPAs is showing great results in early trials. It helps the immune system fight the tumor more…